Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource, 1 online resource.
Language
Englisch

Bibliographic citation
Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review ; volume:12 ; number:1 ; day:20 ; month:4 ; year:2023 ; pages:1-18 ; date:12.2023
Infectious diseases of poverty ; 12, Heft 1 (20.4.2023), 1-18, 12.2023

Creator
Rezapour, Aziz
Behroozi, Zahra
Nasirzadeh, Mostafa
Rezaeian, Mohsen
Barzegar, Mohammad
Tashakori-Miyanroudi, Mahsa
Sayyad, Abdollah
Souresrafil, Aghdas
Contributor
SpringerLink (Online service)

DOI
10.1186/s40249-023-01092-1
URN
urn:nbn:de:101:1-2023083121343676528400
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:57 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Rezapour, Aziz
  • Behroozi, Zahra
  • Nasirzadeh, Mostafa
  • Rezaeian, Mohsen
  • Barzegar, Mohammad
  • Tashakori-Miyanroudi, Mahsa
  • Sayyad, Abdollah
  • Souresrafil, Aghdas
  • SpringerLink (Online service)

Other Objects (12)

Remdesivir-related cost-effectiveness and cost and resource use evidence in COVID-19: a systematic review

Remdesivir-related cost-effectiveness and cost and resource use evidence in COVID-19: a systematic review

Cost-Effectiveness of Combination of Baricitinib and Remdesivir in Hospitalized Patients with COVID-19 in the United States: A Modelling Study

Cost-Effectiveness of Combination of Baricitinib and Remdesivir in Hospitalized Patients with COVID-19 in the United States: A Modelling Study

Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses

Hochschulschrift

Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses

The probability of cost-effectiveness

The probability of cost-effectiveness

Cost-effectiveness analysis for clinicians

Cost-effectiveness analysis for clinicians

Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study

Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study

Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve

Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve

Cost‐effectiveness of intensive care for hospitalized COVID-19 patients: experience from South Africa

Cost‐effectiveness of intensive care for hospitalized COVID-19 patients: experience from South Africa

Cost-Effectiveness Analysis of Remdesivir Treatment in COVID-19 Patients Requiring Low-Flow Oxygen Therapy: Payer Perspective in Turkey

Cost-Effectiveness Analysis of Remdesivir Treatment in COVID-19 Patients Requiring Low-Flow Oxygen Therapy: Payer Perspective in Turkey

Cost-Effectiveness of Targeted Reemployment Bonuses

Arbeitspapier

Cost-Effectiveness of Targeted Reemployment Bonuses

Challenges in synthesising cost-effectiveness estimates

Challenges in synthesising cost-effectiveness estimates

Cost-effectiveness and algorithmic decision-making

Cost-effectiveness and algorithmic decision-making

Related objects